Search Results - "A Tran, Huyen"
-
1
New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism
Published in Medical journal of Australia (01-03-2019)“…Introduction Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most common cardiovascular disease…”
Get full text
Journal Article -
2
-
3
Venous anomalies and thromboembolism
Published in Thrombosis journal (20-04-2023)“…Patients with venous anomalies are at increased risk of developing venous thromboembolism (VTE) and subsequent complications, but they are often…”
Get full text
Journal Article -
4
Tranexamic acid modulates the immune response and reduces postsurgical infection rates
Published in Blood advances (28-05-2019)“…Tranexamic acid (TXA) is an antifibrinolytic agent that blocks plasmin formation. Because plasmin is known to promote inflammatory and immunosuppressive…”
Get full text
Journal Article -
5
Venous Thromboembolism and Estrogen-Containing Gender-Affirming Hormone Therapy
Published in Thrombosis and haemostasis (01-05-2024)“…Gender-affirming therapy involves the use of hormones to develop the physical characteristics of the identified gender and suppressing endogenous sex hormone…”
Get more information
Journal Article -
6
Exploring the effects of Factor Xa inhibitors on thrombin generation in people with haemophilia
Published in Thrombosis research (01-05-2024)“…Optimal management of cardiovascular disease (CVD) in people with haemophilia (PWH) is a growing issue, given the continuing improvement in life expectancy…”
Get full text
Journal Article -
7
Congenital fibrinogen disorders: Strengthening genotype–phenotype correlations through novel genetic diagnostic tools
Published in British journal of haematology (01-11-2023)“…Congenital fibrinogen disorders or CFDs are heterogenous, both in clinical manifestation and array of culprit molecular lesions. Correlations between phenotype…”
Get full text
Journal Article -
8
-
9
Complication rates of central venous access devices in patients with inherited bleeding disorders in Australia
Published in British journal of haematology (01-08-2019)Get full text
Journal Article -
10
Mutational landscape, inhibitor development, and health-care burden in non-severe haemophilia A: A single-centre Australian experience
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01-05-2024)“…To characterise non-severe haemophilia A (HA) patients enrolled on the Australian Bleeding Disorders Registry (ABDR) treated through a state-wide Haemophilia…”
Get full text
Journal Article -
11
Osteoporosis management and falls prevention in patients with haemophilia: Review of haemophilia guidelines
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01-05-2022)“…Introduction Patients with haemophilia (PWH) have a high prevalence of osteoporosis, falls and fractures at all ages. The role of haemophilia itself may…”
Get full text
Journal Article -
12
Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia
Published in Medical journal of Australia (20-09-2021)Get full text
Journal Article -
13
Activation of circulating platelets in vaccine‐induced thrombotic thrombocytopenia and its reversal by intravenous immunoglobulin
Published in British journal of haematology (01-01-2022)Get full text
Journal Article -
14
An update of consensus guidelines for warfarin reversal
Published in Medical journal of Australia (04-03-2013)“…For most warfarin indications, the target international normalised ratio (INR) is 2.0–3.0 (venous thromboembolism and single mechanical heart valve excluding…”
Get full text
Journal Article -
15
Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem
Published in Vaccine (11-05-2023)“…•VITT is a complication ChAdOx1 nCoV19 vaccination (AZD1222) vaccination.•Clinicopathological features suggest a less severe phenotype when compared to…”
Get full text
Journal Article -
16
Approval of the first protease-activated receptor antagonist: Rationale, development, significance, and considerations of a novel anti-platelet agent
Published in Blood reviews (01-05-2015)“…Abstract Twenty-three years after the discovery of the first thrombin receptor, now known as protease-activated receptor 1 (PAR1), the first drug targeting…”
Get full text
Journal Article -
17
Oral Anticoagulant Use in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Review of the Evidence With Recommendations for Australian Clinical Practice
Published in Heart, lung & circulation (01-12-2022)“…Chronic kidney disease is common in patients with atrial fibrillation (AF) and is associated with heightened risks of stroke/systemic embolisation and…”
Get full text
Journal Article -
18
The utility of the Wells clinical prediction model and ventilation-perfusion scanning for pulmonary embolism diagnosis in pregnancy
Published in Blood coagulation & fibrinolysis (01-06-2014)“…Pulmonary embolism is one of the leading causes of mortality in pregnancy in the Western world. No clinical prediction models have been validated in pregnancy…”
Get full text
Journal Article -
19
The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study
Published in The Lancet regional health. Western Pacific (01-11-2023)“…Thrombosis with thrombocytopenia syndrome (TTS) associated with viral vector COVID-19 vaccines, including ChAdOx1-S (AstraZeneca AZD1222) vaccine, can result…”
Get full text
Journal Article -
20
Overcoming aspirin treatment failure in diabetes
Published in Critical reviews in clinical laboratory sciences (01-09-2012)“…People with diabetes have an increased risk of life-threatening cardiovascular disease compared to the general population. Furthermore, people with diabetes…”
Get full text
Journal Article